Research
Neural
GLP-1RA users had a lower risk of stroke (HR, 0.81; 95% CI, 0.70-0.93) compared to other antidiabetic drug users.
Practitioners may consider GLP-1RAs as a treatment option for reducing stroke risk in this population.
StrongSupportsmedium confidence
GLP-1RA users had a lower risk of stroke (HR, 0.81; 95% CI, 0.70-0.93).
Why this rating
Based on the large cohort study design.
Source
Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity
Huan-Tang Lin et al. · JAMA Network Open · 2025
cohort · n=60860Cited 21×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →